-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FN6dzq9ZDT5ZJl/Ceph3/J8PAKGFzyF+QUwvfo9DuTvQib7jkGXh1MzH+Ky2Uvv2 hDf+J5AVyq+MtertzcfECA== 0001230295-06-000180.txt : 20060705 0001230295-06-000180.hdr.sgml : 20060704 20060705165147 ACCESSION NUMBER: 0001230295-06-000180 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060630 FILED AS OF DATE: 20060705 DATE AS OF CHANGE: 20060705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: THOMPSON VIRGIL CENTRAL INDEX KEY: 0001218821 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 06944901 MAIL ADDRESS: STREET 1: 319 SOUTH NARDO CITY: SOIANA BEACH STATE: CA ZIP: 92075 4 1 tho76.xml X0202 4 2006-06-30 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001218821 THOMPSON VIRGIL C/O SAVIENT PHARMACEUTICALS, INC ONE TOWER CENTER BLVD. EAST BRUNSWICK NJ 08816 1 0 0 0 Common Stock, $.01 par value per share 2006-06-30 4 A 0 714 5.2500 A 30320.0000 D Option to Purchase Common Stock, $.01 par value 5.2500 2006-06-30 4 A 0 5000 5.2500 A 2007-06-30 2016-06-30 Common Stock, $.01 par value per share 153150000.0000 5000.0000 D These shares were granted pursuant to the Company's 2004 Incentive Plan, which provides for the grant to non-employee directors of that number of shares of Common Stock having an aggregate fair market value on the last business day of each quarter equal to $3,750.00, until he is no longer an Outside Director. On June 30, 2006, the fair market value of the Common Stock, based on the closing price, was $5.25. These options will become fully vested and immediately exercisable on 6/30/2007. By: Beata A. Smith as Attorney-In-Fact for 2006-06-30 -----END PRIVACY-ENHANCED MESSAGE-----